证券代码：002167 证券简称：东方锆业 公告编号：2025-066 广东东方锆业科技股份有限公司 独立董事候选人声明与承诺 声明人丁浩作为广东东方锆业科技股份有限公司第九届董事会 独立董事候选人，已充分了解并同意由提名人广东东方锆业科技股份 有限公司董事会提名为广东东方锆业科技股份有限公司（以下简称该 公司）第九届董事会独立董事候选人。现公开声明和保证，本人与该 公司之间不存在任何影响本人独立性的关系，且符合相关法律、行政 法规、部门规章、规范性文件和深圳证券交易所业务规则对独立董事 候选人任职资格及独立性的要求，具体声明并承诺如下事项： 一、本人已经通过广东东方锆业科技股份有限公司第八届董事会 提名委员会或者独立董事专门会议资格审查，提名人与本人不存在利 害关系或者其他可能影响独立履职情形的密切关系。 ☑ 是 □ 否 如否，请详细说明：______________________________ 二、本人不存在《中华人民共和国公司法》第一百七十八条等规 定不得担任公司董事的情形。 ☑ 是 □ 否 如否，请详细说明：______________________________ 三、本人符合中国证监会《上市 ...

证券代码：002167 证券简称：东方锆业 公告编号：2025-059 广东东方锆业科技股份有限公司 公司第九届董事会由7名董事组成，其中非独立董事4名（包括职 工代表董事1名，由公司职工代表大会选举产生），独立董事3名。经 公司董事会提名委员会资格审查，公司董事会同意提名申庆飞先生、 冯立明先生、甘学贤先生为公司第九届董事会非独立董事候选人；同 意提名石勇先生、刘家祥先生、丁浩先生为公司第九届董事会独立董 事候选人，其中石勇先生为会计专业人士；与后续职工代表大会选举 产生的职工代表董事一起，共同组成公司第九届董事会，任期自公司 股东大会审议通过之日起三年。相关候选人简历详见附件。 上述董事候选人人数符合《公司法》的规定，其中独立董事候选 人人数的比例未少于董事会人员的三分之一。三位独立董事候选人中 除石勇先生外均已取得独立董事资格证书，石勇先生已向公司书面承 诺将参加深圳证券交易所组织的最近一期独立董事培训，并承诺取得 深圳证券交易所认可的独立董事资格证书。独立董事候选人相关任职 资格和独立性尚需经深圳证券交易所审核无异议后，方可与其他3名 非独立董事候选人一并提交公司股东大会审议。公司第九届董事会董 事( ...

证券代码：002167 证券简称：东方锆业 公告编号：2025-063 广东东方锆业科技股份有限公司 独立董事提名人声明与承诺 提名人广东东方锆业科技股份有限公司董事会现就提名丁浩为 广东东方锆业科技股份有限公司第九届董事会独立董事候选人发表 公开声明。被提名人已书面同意作为广东东方锆业科技股份有限公司 第九届董事会独立董事候选人（参见该独立董事候选人声明）。本次 提名是在充分了解被提名人职业、学历、职称、详细的工作经历、全 部兼职、有无重大失信等不良记录等情况后作出的，本提名人认为被 提名人符合相关法律、行政法规、部门规章、规范性文件和深圳证券 交易所业务规则对独立董事候选人任职资格及独立性的要求，具体声 明并承诺如下事项： 如否，请详细说明：______________________________ 二、被提名人不存在《中华人民共和国公司法》第一百七十八条 等规定不得担任公司董事的情形。 ☑ 是 □ 否 如否，请详细说明：______________________________ 三、被提名人符合中国证监会《上市公司独立董事管理办法》和 深圳证券交易所业务规则规定的独立董事任职资格和条件。 一、被提名 ...

证券代码：002167 证券简称：东方锆业 公告编号：2025-060 广东东方锆业科技股份有限公司 关于修订《公司章程》及修订、制定 公司部分治理制度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 广东东方锆业科技股份有限公司（以下简称"公司"）于 2025 年 12 月 5 日召开第八届董事会第二十六次会议，审议通过了《关于 修订<公司章程>及其附件的议案》和《关于修订、制定公司部分治 理制度的议案》，该议案中部分议案尚需提交公司股东大会审议，现 将具体情况公告如下： 一、关于修订《公司章程》及其附件的情况 根据《中华人民共和国公司法》《关于新<公司法>配套制度规 则实施相关过渡期安排》《中华人民共和国证券法》以及《上市公司 章程指引（2025 年修订）》等法律法规、规范性文件的最新规定， 结合公司实际情况，公司将不再设置监事会，监事会的职权由董事会 审计委员会行使。 针对上述情形，公司拟对《公司章程》及其附件《股东大会议事 规则》《董事会议事规则》的部分条款做相应修订、完善，并将《股 东大会议事规则》更名为《股东会议事规则》，相应废止《监事会议 ...

证券代码：002167 证券简称：东方锆业 公告编号：2025-067 广东东方锆业科技股份有限公司 关于召开 2025 年第五次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 根据广东东方锆业科技股份有限公司（以下简称"公司"）第八 届董事会第二十六次会议决议，决定于2025年12月22日召开公司2025 年第五次临时股东大会。现将有关会议事宜通知如下： 一、召开会议基本情况 1、会议届次：2025年第五次临时股东大会 2、会议召集人：公司董事会 3、会议召开的合法、合规性：公司2025年第五次临时股东大会 的召集程序符合有关法律、行政法规、部门规章、规范性文件和《公 司章程》的有关规定。 （2）网络投票：公司将通过深圳证券交易所交易系统和互联网 投票系统（http://wltp.cninfo.com.cn）向全体股东提供网络投票平台， 股东可以在网络投票时间内通过上述系统行使表决权。 投票表决时，同一表决权只能选择现场投票、深交所交易系统投 票、深交所互联网系统投票中的一种，不能重复投票。如果同一表决 权通过现场、交易系统和互联网重复投 ...

证券代码：002167 证券简称：东方锆业 公告编号：2025-058 广东东方锆业科技股份有限公司 第八届董事会第二十六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 广东东方锆业科技股份有限公司（以下简称"公司"）董事会于2025 年12月4日以专人送达、邮件等方式向全体董事发出了召开第八届董事会 第二十六次会议的通知及材料，会议于2025年12月5日下午15:00在公司 总部办公楼会议室以现场与通讯相结合的方式召开。会议应出席董事7 名，实际出席本次会议7名，会议由公司董事长冯立明主持，公司监事会 成员、高级管理人员列席了本次会议。本次会议符合《公司法》和《公 司章程》的有关规定，合法有效。 会议采用记名投票的方式进行表决，经与会董事表决，审议通过了 以下议案： 一、逐项审议通过了《关于公司董事会换届选举非独立董事的议案》 1.01选举申庆飞先生为公司第九届董事会非独立董事 表决结果：同意7票，反对0票，弃权0票。 1.02选举冯立明先生为公司第九届董事会非独立董事 表决结果：同意7票，反对0票，弃权0票。 1.01选举甘学贤先生为公司第 ...

Core Viewpoint - Dongfang Zirconium plans to invest significantly in new energy battery-related projects, focusing on the production of high-purity zirconium compounds to enhance its competitive edge and profitability [1][2]. Investment Project - The company’s wholly-owned subsidiary, Qinyang Dong Zirconium New Materials Technology Co., Ltd., intends to invest 737 million yuan to establish a project with an annual production capacity of 60,000 tons of battery-grade zirconium oxychloride and 12,000 tons of high-purity zirconium-hafnium separation oxides [2][3]. - The project will be constructed in two phases: the first phase will produce 35,000 tons/year of high-purity zirconium oxychloride, and the second phase will produce 25,000 tons/year of high-purity zirconium oxychloride and 12,000 tons/year of oxides, including 2,000 tons/year of nuclear-grade zirconium [2]. Market Position and Strategy - Dongfang Zirconium aims to accelerate its layout in emerging application fields supported by national policies, enhancing its core competitiveness and profitability through this new project [2][3]. - The company has been actively developing downstream applications for zirconium products, with its zirconium oxide powder already being used as an additive in ternary cathode materials and gaining preliminary recognition from solid-state battery material manufacturers [3]. Research and Development - The company has invested in R&D, with expenditures of 56.53 million yuan, 63.24 million yuan, 74.28 million yuan, and 49.99 million yuan from 2021 to 2024, and 46.79 million yuan in the first three quarters of 2025 [4][5]. - Dongfang Zirconium holds 20 invention patents and 76 utility model patents, having developed a series of new products and processes, including high-purity ultra-fine zirconium dioxide and high-performance composite zirconium [5]. Financial Performance - In the first three quarters of 2025, the company reported a net profit of 38.68 million yuan, a year-on-year increase of 193.66%, marking a turnaround from previous losses [1][6]. - The company’s revenue for the same period was 927 million yuan, reflecting a year-on-year decline of 24.86% [6].

Core Viewpoint - Dongfang Zircon Industry plans to invest approximately 737 million yuan in a project to produce 60,000 tons of battery-grade zirconium oxychloride and 12,000 tons of high-purity zirconium-hafnium separation oxide annually, indicating a strategic shift towards emerging applications in solid-state batteries and nuclear power [2][3][4]. Investment Details - The investment will be executed through its wholly-owned subsidiary, Qinyang Dongzhuo New Materials Technology Co., Ltd., and will be carried out in two phases, with the first phase focusing on 35,000 tons/year of high-purity zirconium oxychloride and the second phase adding 25,000 tons/year and 12,000 tons/year of oxide [3][4]. - The total investment for the two projects, including a related asset acquisition of 66.57 million yuan, amounts to nearly 800 million yuan [2][4]. Strategic Shift - The company is transitioning from traditional zircon products to high-end emerging fields such as new energy, photovoltaics, and nuclear power due to declining demand in traditional sectors [3][4]. - Cumulatively, Dongfang Zircon's planned investments in emerging applications this year will reach approximately 1.1 billion yuan, demonstrating a strong commitment to this strategic direction [6]. Financial Considerations - The funding for the 737 million yuan project is expected to come from self-owned or self-raised funds, which poses a significant financial burden given the company's current cash position of only 290 million yuan as of the end of Q3 [6][9]. - The company has faced increased financial pressure, with accounts receivable skyrocketing by 47 times to 119 million yuan, primarily due to an increase in commercial bills received [6][9]. Market and Technical Challenges - There are concerns regarding the production progress of solid-state battery materials, as the company has not yet supplied products to solid-state battery manufacturers, despite market speculation that the investment signals imminent mass production [6][9]. - The solid-state battery electrolyte market is characterized by competition among three main technical routes: polymer, oxide, and sulfide, with Dongfang Zircon focusing on the oxide route, which presents risks related to technological iteration and market competition [9][10].

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Core Viewpoint - Guangdong Dongfang Zirconium Industry Co., Ltd. has approved significant investment projects aimed at expanding its production capacity in the zirconium industry, specifically focusing on the production of battery-grade zirconium oxychloride and high-purity zirconium-hafnium separation oxides [15][19]. Group 1: Investment Projects - The company has approved the investment in a project to construct an annual production capacity of 60,000 tons of battery-grade zirconium oxychloride and 12,000 tons of high-purity zirconium-hafnium separation oxides [2][15]. - The project will be executed in two phases: the first phase will establish a production line for 35,000 tons/year of high-purity zirconium oxychloride, while the second phase will add another 25,000 tons/year and 12,000 tons/year of oxides [15][17]. - The total investment budget for the project is estimated at 737 million yuan, with funding sourced from the company's own or self-raised funds [17][19]. Group 2: Asset Purchase and Related Transactions - The company has also approved a related transaction involving the purchase of assets from Longbai Group's subsidiary for 66.5743 million yuan, which includes land and buildings necessary for the new production project [19][20]. - This transaction is classified as a related party transaction, as the seller is a wholly-owned subsidiary of the company's controlling shareholder [20][21]. - The asset purchase is expected to enhance the company's operational efficiency and align with its strategic development goals, ensuring no adverse impact on the company's financial health [40][42]. Group 3: Strategic Implications - The investment and asset acquisition are aligned with the company's long-term development strategy, focusing on high-tech and high-value-added business expansion in emerging applications of zirconium products [16][40]. - The projects are expected to strengthen the company's core competitiveness and profitability, contributing to sustainable development and scale efficiency [16][40]. - The company emphasizes that these initiatives will not harm the interests of shareholders, particularly minority shareholders, and are in compliance with national industrial policies [16][40].